Folgen
Keine Story von Qiagen N.V. mehr verpassen.

Qiagen N.V.

Filtern
  • 06.04.2017 – 17:22

    QIAGEN Posts 2016 Annual Report on Its Website

    Venlo the Netherlands (ots) - QIAGEN N.V. (Nasdaq: QGEN) (Frankfurt: QIA) has posted its 2016 Annual Report on its website at http://ots.de/YwER5. QIAGEN's Annual Report on Form 20-F for the year ended December 31, 2016 has been filed with the U.S. Securities and Exchange Commission (SEC) on March 3, 2017, a copy of which can be found on the website of the SEC at www.sec.gov or in the 'Financial Information' section of ...

  • 13.04.2016 – 17:39

    QIAGEN Posts 2015 Annual Report on Its Website

    Venlo, The Netherlands (ots/PRNewswire) - QIAGEN N.V. (Nasdaq:QGEN) (Frankfurt:QIA) has posted its 2015 Annual Report on its website at http://www.qiagen.com/About-Us/Investors/Financial-Information/Financial-Reports QIAGEN's Annual Report on Form 20-F for the year ended December 31, 2015 has been filed with the U.S. Securities and Exchange Commission (SEC) on February 26, 2016, a copy of which can be found on the website ...

  • 04.05.2015 – 17:59

    QIAGEN Posts 2014 Annual Report on Its Website

    Venlo, The Netherlands (ots/PRNewswire) - QIAGEN N.V. has posted its 2014 Annual Report on its website at http://www.qiagen.com/About-Us/Investors/Financial-Information/Financial-Reports QIAGEN's Annual Report on Form 20-F for the year ended December 31, 2014 has been filed with the U.S. Securities and Exchange Commission (SEC) on February 27, 2015, a copy of which can be found on the website of the SEC at ...

  • 02.11.2011 – 01:30

    Home-based self-collected vaginal specimens detect more cervical lesions and cancers than cytology

    Hilden, Germany, and Gaithersburg, Md. (ots) - Vaginal self-collection for Hybrid Capture®-based HPV testing increases screening coverage and is more sensitive than Pap smear shows a Mexican study published today online in the Lancet Promising findings published today online in the Lancet[i] from a community- based, randomized equivalence trial undertaken by public ...

  • 06.06.2008 – 15:29

    Ending Cervical Cancer Featured at Summit; QIAGEN CEO Issues a Call to Global Women Leaders

    Hanoi, Vietnam (ots/PRNewswire) - QIAGEN was featured this week for its efforts to eliminate cervical cancer at the 14th annual Global Summit of Women in Hanoi, Vietnam. CEO Peer Schatz came to this prominent international platform to issue a call to other leaders in business, NGOs and governments to join him and campaign to create a cervical-cancer-free world. ...

  • 08.11.2007 – 07:33

    Study Finds New Version of QIAGEN's HPV Test for Developing Countries Could Reduce Risk of Cervical Cancer by More than Half When Combined With Appropriate Treatment

    Beijing, November 8 (ots/PRNewswire) - - Research Shows the New Test is Accurate, Simple to Run and Requires Minimal Resources Research demonstrating the potential of a special type of HPV test developed by QIAGEN with support from PATH -- a non-profit global health organization -- to reduce the incidence ...

  • 18.10.2007 – 12:46

    NEJM Report Finds HPV Test More Effective Than Pap in Determining Cervical Cancer Risk

    Gaithersburg, Maryland and Hilden, Germany (ots/PRNewswire) - The first randomized, controlled study in North America of HPV testing as a stand-alone screen concluded that it is almost 40 percent more accurate than traditional cytology (the Pap "smear") in identifying women with advanced cervical disease, according to a report published today in The New England ...